Reduction versus abrupt ces- sation in smokers who want to quit. Cochrane Database Syst Rev. 2010:CD008033. 304. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessa- tion intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233 239. 305. Fiore MC, Ja n CR. A clinical blueprint to accelerate the elimina- tion of tobacco use. JAMA. 2008;299:2083 2085. doi: 10.1001/ jama.299.17.2083. 306. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scien- tific review. Circulation. 2014;129:1972 1986. doi: 10.1161/ CIRCULATIONAHA.114.007667. 307. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Antonnucio DO, Hartman N, McGovern PG. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335:1792 1798. doi: 10.1056/NEJM199612123352402. 308. Meine TJ, Patel MR, Washam JB, Pappas PA, Jollis JG. Safety and effec- tiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol. 2005;95:976 978. doi: 10.1016/j. amjcard.2004.12.039. 309. Paciullo CA, Short MR, Steinke DT, Jennings HR. Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery. Ann Pharmacother. 2009;43:1197 1202. doi: 10.1345/aph.1L423. 310. Eisenberg MJ, Grandi SM, Gervais A, O Loughlin J, Paradis G, Rinfret S, Sarrafzadegan N, Sharma S, Lauzon C, Yadav R, Pilote L; ZESCA Investigators. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial. J Am Coll Cardiol. 2013;61:524 532. doi: 10.1016/j.jacc.2012.08.1030. 311. Planer D, Lev I, Elitzur Y, Sharon N, Ouzan E, Pugatsch T, Chasid M, Rom M, Lotan C. Bupropion for smoking cessation in patients with acute coronary syndrome. Arch Intern Med. 2011;171:1055 1060. doi: 10.1001/archinternmed.2011.72. 312. 